Atyr PHARMA INC (NASDAQ:ATYR) Receives $19.25 Consensus PT from Brokerages
Atyr PHARMA INC (NASDAQ:ATYR – Get Free Report) has been assigned a consensus rating of “Buy” from the seven ratings firms that are currently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month […]
Atyr PHARMA INC (NASDAQ:ATYR – Get Free Report) has been assigned a consensus rating of “Buy” from the seven ratings firms that are currently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month […]
